Inactivating mutations of CYLD underlie the CYLD cutaneous syndrome, a disease characterized by the development of benign skin tumors of the hair follicles (39) including multiple familial trichoepithelioma, the Brooke–Spiegler syndrome, and familial cylindromatosis. The gene discussed is CYLD; the disease is Brooke-Spiegler syndrome.